Irradiation of Very Locally Advanced and Recurrent Rectal Cancer

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Adjuvant therapy with chemoradiation or short-course radiation in addition to improvements in surgical technique has led to improved outcomes for patients with locally advanced rectal cancer. Local recurrence rates of less than 10% and 5-year survival rate of 60% or higher is expected. However, for patients with very locally advanced primary or locally recurrent disease in whom surgical resection is likely to be associated with incomplete resection, survival and disease control rates are poor and standard doses of adjuvant radiation or chemoradiation are relatively ineffective. Dose-escalation approaches with intraoperative radiation (IORT) have been explored in both the primary and recurrent setting. Although high-level evidence is lacking, available data suggest improvements in local and distant control leading to improved survival with IORT approaches. This review summarizes the evidence for dose-escalation approaches with IORT for patients with very locally advanced and recurrent rectal cancer.

Original languageEnglish (US)
Pages (from-to)226-235
Number of pages10
JournalSeminars in Radiation Oncology
Volume26
Issue number3
DOIs
StatePublished - Jul 1 2016

Fingerprint

Rectal Neoplasms
Radiation
Survival
Survival Rate
Recurrence
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Irradiation of Very Locally Advanced and Recurrent Rectal Cancer. / Haddock, Michael.

In: Seminars in Radiation Oncology, Vol. 26, No. 3, 01.07.2016, p. 226-235.

Research output: Contribution to journalReview article

@article{59a615afa1b14e84a49fc5b9688f8b00,
title = "Irradiation of Very Locally Advanced and Recurrent Rectal Cancer",
abstract = "Adjuvant therapy with chemoradiation or short-course radiation in addition to improvements in surgical technique has led to improved outcomes for patients with locally advanced rectal cancer. Local recurrence rates of less than 10{\%} and 5-year survival rate of 60{\%} or higher is expected. However, for patients with very locally advanced primary or locally recurrent disease in whom surgical resection is likely to be associated with incomplete resection, survival and disease control rates are poor and standard doses of adjuvant radiation or chemoradiation are relatively ineffective. Dose-escalation approaches with intraoperative radiation (IORT) have been explored in both the primary and recurrent setting. Although high-level evidence is lacking, available data suggest improvements in local and distant control leading to improved survival with IORT approaches. This review summarizes the evidence for dose-escalation approaches with IORT for patients with very locally advanced and recurrent rectal cancer.",
author = "Michael Haddock",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/j.semradonc.2016.02.004",
language = "English (US)",
volume = "26",
pages = "226--235",
journal = "Seminars in Radiation Oncology",
issn = "1053-4296",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Irradiation of Very Locally Advanced and Recurrent Rectal Cancer

AU - Haddock, Michael

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Adjuvant therapy with chemoradiation or short-course radiation in addition to improvements in surgical technique has led to improved outcomes for patients with locally advanced rectal cancer. Local recurrence rates of less than 10% and 5-year survival rate of 60% or higher is expected. However, for patients with very locally advanced primary or locally recurrent disease in whom surgical resection is likely to be associated with incomplete resection, survival and disease control rates are poor and standard doses of adjuvant radiation or chemoradiation are relatively ineffective. Dose-escalation approaches with intraoperative radiation (IORT) have been explored in both the primary and recurrent setting. Although high-level evidence is lacking, available data suggest improvements in local and distant control leading to improved survival with IORT approaches. This review summarizes the evidence for dose-escalation approaches with IORT for patients with very locally advanced and recurrent rectal cancer.

AB - Adjuvant therapy with chemoradiation or short-course radiation in addition to improvements in surgical technique has led to improved outcomes for patients with locally advanced rectal cancer. Local recurrence rates of less than 10% and 5-year survival rate of 60% or higher is expected. However, for patients with very locally advanced primary or locally recurrent disease in whom surgical resection is likely to be associated with incomplete resection, survival and disease control rates are poor and standard doses of adjuvant radiation or chemoradiation are relatively ineffective. Dose-escalation approaches with intraoperative radiation (IORT) have been explored in both the primary and recurrent setting. Although high-level evidence is lacking, available data suggest improvements in local and distant control leading to improved survival with IORT approaches. This review summarizes the evidence for dose-escalation approaches with IORT for patients with very locally advanced and recurrent rectal cancer.

UR - http://www.scopus.com/inward/record.url?scp=84969822543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969822543&partnerID=8YFLogxK

U2 - 10.1016/j.semradonc.2016.02.004

DO - 10.1016/j.semradonc.2016.02.004

M3 - Review article

VL - 26

SP - 226

EP - 235

JO - Seminars in Radiation Oncology

JF - Seminars in Radiation Oncology

SN - 1053-4296

IS - 3

ER -